Mark J. Vignola's Net Worth

$70.8 Thousand

Estimate Recalculated Jul 17, 2024 07:55PM EST

Who is Mark J. Vignola?

Mark J. Vignola does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Terns Pharmaceuticals, Inc., and Applied Therapeutics Inc..

SEC CIK

Mark J. Vignola's CIK is 0001775429

Past Insider Trading and Trends

2022 was Mark J. Vignola's most active year for acquiring shares with 3 total transactions. Mark J. Vignola's most active month to acquire stocks was the month of April. 2023 saw Mark J. Vignola paying a total of $16,904.31 for 370,740 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $5.38

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.50%
4.79K
$4.44
$21,272.04
91.94K
May 31
Form 4
+373.66%
68.75K
—
—
87.15K
Jan 23
Form 4
+4.21%
743
$3.78
$2,808.54
18.4K
Nov 30
Form 4
+130.53%
10K
$1.41
$14,095.77
17.66K
May 31
Form 4
+0.04%
3
$1.41
$4.23
7.66K
Nov 30 - Feb 1
Form 4
∞
7.66K
$1.47
$11,254.32
7.66K
May 31
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Sep 28
Form 3
—
0
—
—
0
No matching records found

Applied Therapeutics Inc. (APLT) Snapshot price: $2.795

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 13
Form 3
—
0
—
—
0
No matching records found